Latest news from Yale Cancer Center/Smilow Cancer Hospital on News en-us Copyright 2025 News 115 31 / /images/newswise-logo-rss.gif /articles/lupus-related-antibody-shows-promise-in-enhancing-cancer-treatment-efficacy/?sc=rsin /articles/lupus-related-antibody-shows-promise-in-enhancing-cancer-treatment-efficacy/?sc=rsin Tue, 25 Mar 2025 19:40:17 EST The Yale research, published in Science Signaling on March 25, offers new findings that could help improve therapies for glioblastoma and other aggressive cancers that are difficult to treat. Yale Cancer Center/Smilow Cancer Hospital /articles/smilow-cancer-hospital-nurses-to-present-at-world-s-largest-oncology-nursing-conference2/?sc=rsin /articles/smilow-cancer-hospital-nurses-to-present-at-world-s-largest-oncology-nursing-conference2/?sc=rsin Tue, 25 Mar 2025 17:30:31 EST Nurses from Yale New Haven Health's Smilow Cancer Hospital (SCH) will showcase their latest research from April 9-13 at the 50th Annual Congress of the Oncology Nursing Society (ONS) in Denver, Colo. ONS, a professional organization comprising of more than 35,000 healthcare professionals, hosts this international event for nursing oncology professionals to exchange knowledge and advance the field of cancer care. Yale Cancer Center/Smilow Cancer Hospital /articles/yale-surgeons-to-present-at-international-surgical-oncology-conference/?sc=rsin /articles/yale-surgeons-to-present-at-international-surgical-oncology-conference/?sc=rsin Mon, 24 Mar 2025 10:55:32 EST Yale Department of Surgery oncologists and trainees at Yale Cancer Center will present new findings at the Society of Surgical Oncology (SSO) Annual Meeting in Tampa, Fla., from March 27-29. The conference focuses on improving surgical cancer care for patients through educational sessions as well as oral and poster presentations for surgical oncologists, researchers, and patient advocates. Yale Cancer Center/Smilow Cancer Hospital /articles/a-post-treatment-blood-test-could-inform-future-cancer-therapy-decisions/?sc=rsin /articles/a-post-treatment-blood-test-could-inform-future-cancer-therapy-decisions/?sc=rsin Mon, 17 Mar 2025 08:25:22 EST A new study led by Dr. Roy Herbst, deputy director of Yale Cancer Center, found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer, years after their treatment. Yale Cancer Center/Smilow Cancer Hospital /articles/studying-chemical-exposure-and-brain-cancer-risk-in-firefighters/?sc=rsin /articles/studying-chemical-exposure-and-brain-cancer-risk-in-firefighters/?sc=rsin Mon, 10 Mar 2025 08:40:45 EST The study co-led by Dr. Elizabeth Claus of Yale Cancer Center showed an increased presence of haloalkane-associated mutational signatures in the firefighters' tumors. Yale Cancer Center/Smilow Cancer Hospital /articles/mehra-golshan-md-mba/?sc=rsin /articles/mehra-golshan-md-mba/?sc=rsin Wed, 05 Feb 2025 20:20:49 EST Mehra Golshan, MD, MBA, a professor of surgery at Yale School of Medicine and executive vice chair in the Department of Surgery, will be awarded a 2025 Ellis Island Medal of Honor from the Ellis Island Honors Society. The medal recognizes Golshan's contributions to breast cancer treatment and research, his dedication to patient care, and his commitment to mentorship. Yale Cancer Center/Smilow Cancer Hospital /articles/personalized-therapeutic-vaccine-steers-the-immune-system-to-fight-kidney-cancer/?sc=rsin /articles/personalized-therapeutic-vaccine-steers-the-immune-system-to-fight-kidney-cancer/?sc=rsin Wed, 05 Feb 2025 11:25:52 EST Personalized cancer vaccines (PCVs) train the body's immune system to recognize and destroy a threat. In this trial, all nine patients who received multiple doses of the vaccine had an immune response within a three-week period and cancer fighting T cells remained elevated for the duration of the study and for years afterward. Yale Cancer Center/Smilow Cancer Hospital /articles/factors-for-exceptional-response-kidney-cancer/?sc=rsin /articles/factors-for-exceptional-response-kidney-cancer/?sc=rsin Thu, 09 Jan 2025 09:05:29 EST Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, historically has presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when the tumor substantially shrinks for a very long period of time) for some patients with mccRRC, allowing them to live longer with a better quality of life. Yale Cancer Center/Smilow Cancer Hospital /articles/drug-offers-cost-effective-protection-for-newborns-with-genetic-bleeding-disorder/?sc=rsin /articles/drug-offers-cost-effective-protection-for-newborns-with-genetic-bleeding-disorder/?sc=rsin Thu, 05 Dec 2024 14:10:04 EST Severe hemophilia A is a genetic disorder that prevents blood from clotting properly, posing a constant risk of dangerous bleeding episodes. Infants with severe hemophilia A (HA) are at risk of brain bleeds, which can lead to serious long-term brain damage. Emicizumab (Hemlibra) was approved by the FDA in 2018 to prevent and reduce bleeding for patients who suffer from hemophilia A. Yale Cancer Center/Smilow Cancer Hospital /articles/unexpected-findings-in-study-of-t-cells-considered-front-line-fighters-against-advanced-melanoma/?sc=rsin /articles/unexpected-findings-in-study-of-t-cells-considered-front-line-fighters-against-advanced-melanoma/?sc=rsin Mon, 02 Dec 2024 09:10:56 EST Yale researchers made an unexpected discovery--turncoat T cells that help a tumor evade other cancer-fighting immune T cells--in a study of patients living with advanced melanoma that was published Nov. 28 in Nature Immunology. Yale Cancer Center/Smilow Cancer Hospital /articles/yale-cancer-center-to-highlight-breakthroughs-in-blood-cancers-and-disorders-at-world-s-largest-hematology-meeting/?sc=rsin /articles/yale-cancer-center-to-highlight-breakthroughs-in-blood-cancers-and-disorders-at-world-s-largest-hematology-meeting/?sc=rsin Tue, 26 Nov 2024 14:15:29 EST Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the 66th annual American Society of Hematology (ASH) annual meeting in San Diego, Calif., December 7-10. Known as "the premier event in classical and malignant hematology", the ASH meeting includes oral and poster presentations, as well as workshops and educational sessions for hematology professionals and advocates. Yale Cancer Center/Smilow Cancer Hospital /articles/advancing-breast-cancer-research-yale-cancer-center-to-share-insights-at-international-conference/?sc=rsin /articles/advancing-breast-cancer-research-yale-cancer-center-to-share-insights-at-international-conference/?sc=rsin Tue, 26 Nov 2024 09:15:47 EST Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the 47th annual San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center from December 10 to 13. Yale Cancer Center/Smilow Cancer Hospital /articles/more-patients-opting-for-close-monitoring-of-early-stage-prostate-cancer/?sc=rsin /articles/more-patients-opting-for-close-monitoring-of-early-stage-prostate-cancer/?sc=rsin Fri, 22 Nov 2024 11:50:44 EST Prostate cancer is the second most commonly diagnosed cancer in men (behind skin cancer), with varying levels of aggressiveness. It's also the second leading cause of cancer death, behind only lung cancer. A new study led by Yale Cancer Center researchers at Yale School Medicine found a substantial increase in the adoption of active surveillance (AS) and watchful waiting (WW) treatment strategies over the past decade -- an encouraging trend for men seeking less invasive treatment options. Yale Cancer Center/Smilow Cancer Hospital /articles/william-k-oh-md-joins-yale-cancer-center-and-smilow-cancer-hospital/?sc=rsin /articles/william-k-oh-md-joins-yale-cancer-center-and-smilow-cancer-hospital/?sc=rsin Tue, 05 Nov 2024 09:40:10 EST William K. Oh, MD, has been appointed as Medical Director of Smilow Cancer Hospital at Greenwich Hospital, as well as Director of Precision Medicine for Yale Cancer Center and Smilow Cancer Hospital. Yale Cancer Center/Smilow Cancer Hospital /articles/living-flat-study-sheds-light-on-challenges-for-women-of-color-after-breast-cancer-surgery/?sc=rsin /articles/living-flat-study-sheds-light-on-challenges-for-women-of-color-after-breast-cancer-surgery/?sc=rsin Mon, 28 Oct 2024 13:50:55 EST A new study led by Yale Cancer Center researchers at Yale School of Medicine titled, "Living Flat: Stories from Women of Color After Mastectomy," explains how cultural factors, spirituality, and personal beliefs play an important role in the lives of women of color after mastectomies. Yale Cancer Center/Smilow Cancer Hospital /articles/yale-cancer-center-expert-to-receive-kidney-cancer-association-s-rising-star-award/?sc=rsin /articles/yale-cancer-center-expert-to-receive-kidney-cancer-association-s-rising-star-award/?sc=rsin Fri, 25 Oct 2024 14:50:44 EST Dr. David Braun, a medical oncologist at Yale Cancer Center, will be awarded the Christopher G. Wood Rising Star Award by the Kidney Cancer Association at November's International Kidney Cancer Symposium. Yale Cancer Center/Smilow Cancer Hospital /articles/study-reveals-disparities-in-colorectal-cancer-screening/?sc=rsin /articles/study-reveals-disparities-in-colorectal-cancer-screening/?sc=rsin Thu, 03 Oct 2024 11:05:23 EST Significantly more younger people underwent colorectal cancer screening after the recommended age to begin such screening was lowered, Yale researchers report. In a new study of 10 million insured people aged 45 to 49, researchers found that a recommendation by the United States Preventative Services Task Force to drop the age for starting colorectal cancer screening by five years to age 45 was highly effective -- tripling the rate of screening overall -- but the magnitude of increase was significantly smaller for low-income and rural populations. Yale Cancer Center/Smilow Cancer Hospital /articles/yale-cancer-center-expert-available-to-discuss-new-american-cancer-society-report-revealing-higher-rates-of-early-onset-breast-cancer-and-disparities-in-underserved-populations/?sc=rsin /articles/yale-cancer-center-expert-available-to-discuss-new-american-cancer-society-report-revealing-higher-rates-of-early-onset-breast-cancer-and-disparities-in-underserved-populations/?sc=rsin Wed, 02 Oct 2024 12:05:56 EST Yale Cancer Center/Smilow Cancer Hospital /articles/new-barcode-technology-could-help-diagnose-cancer-more-precisely/?sc=rsin /articles/new-barcode-technology-could-help-diagnose-cancer-more-precisely/?sc=rsin Mon, 30 Sep 2024 11:05:51 EST A new pathology tool created at Yale harnesses barcode technology and shows potential for use in cancer diagnoses. The technology, Patho-DBiT (pathology-compatible deterministic barcoding in tissue), was discussed in a new study that published Sept. 30 in the journal Cell. Co-corresponding author Dr. Mina Xu, a Yale Cancer Center (YCC) member, professor of pathology at Yale School of Medicine (YSM), and the YSM director of hematopathology, shared her enthusiasm for the new tool. Yale Cancer Center/Smilow Cancer Hospital /articles/is-comprehensive-genetic-testing-worth-it-for-cancer-patients/?sc=rsin /articles/is-comprehensive-genetic-testing-worth-it-for-cancer-patients/?sc=rsin Tue, 24 Sep 2024 12:05:49 EST Comprehensive gene panel testing, one of the exciting new tools in cancer diagnostics, warrants greater scrutiny -- as does a federal program aimed at speeding up the review process for proposed new medical technologies. Those are conclusions of Yale medical experts who studied both and published a report in the Journal of the National Cancer Institute on Sept. Yale Cancer Center/Smilow Cancer Hospital